EBITDA: Income before interest, taxes, depreciation and amortization.
Precision BioSciences, Inc. (DTIL) had EBITDA of $13.19M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$34.20M |
|
$20.13M |
|
-- |
|
$34.20M |
|
$21.70M |
|
$12.51M |
|
$6.74M |
|
$19.25M |
|
$20.35M |
|
$19.25M |
|
$19.25M |
|
$20.13M |
|
$20.35M |
|
$12.51M |
|
|
EBITDA |
$13.19M |
12.83M |
|
12.83M |
|
$2.62 |
|
$2.62 |
|
| Balance Sheet Financials | |
$118.74M |
|
$1.43M |
|
$35.68M |
|
$154.42M |
|
$8.91M |
|
$22.40M |
|
$53.26M |
|
$62.17M |
|
$92.25M |
|
$91.08M |
|
$92.25M |
|
24.09M |
|
| Cash Flow Statement Financials | |
$-65.84M |
|
$-0.63M |
|
$95.16M |
|
$108.47M |
|
$137.15M |
|
$28.68M |
|
$10.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.32 |
|
-- |
|
-- |
|
0.20 |
|
0.24 |
|
100.00% |
|
36.57% |
|
36.57% |
|
-- |
|
56.27% |
|
58.86% |
|
$-65.86M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
-- |
|
-- |
|
-- |
|
20.87% |
|
21.13% |
|
12.46% |
|
16.79% |
|
$3.83 |
|
$-5.13 |
|
$-5.13 |
|